CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 1 enrolled
Drug / intervention
Ferrous Sulfate +1 moredrug
Likely dose
Ferrous Sulfate 3 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04371536
NCT04371536Phase 3Completed

A Single-Center, Open-Label, Randomized Feasibility Trial of Standard Oral Iron Therapy Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children With Nutritional Iron Deficiency Anemia

Baylor College of Medicine·interventional·Posted May 1, 2020·Updated May 6, 2023

In Brief

A Phase 3 clinical trial evaluating Ferrous Sulfate and IRONCHILD for Iron Deficiency Anemia and Iron-deficiency. Completed, enrolled 1 participant across 1 site.

Detailed Summary

Iron deficiency anemia (IDA) affects nearly half a million young children in the United States. Most children take liquid iron medicine by mouth for at least 3 months. However, some children take longer to get better with this medicine. This study is trying to compare different ways of giving iron medicine to young children. For young children in the US, the main cause of IDA is nutritional, or not having enough iron in the foods they eat. This often happens when kids drink too much cow milk and/or not eating enough foods that have a lot of iron. Iron deficiency is most common in children ages 1 to 4 years of age, during a time that is important for brain development. More severe and long-lasting IDA is associated with worse brain development outcomes. That is why researchers want to understand the fastest way for kids with IDA to get better. Standard treatment is oral iron medicine for 3 to 6 months. Many children do not take their iron medicine the full amount of time needed because of side effects like abdominal discomfort, nausea, constipation, and bad taste. Different factors can contribute to patients not completing their IDA therapy. Many families do not understand how important it is to treat IDA or do not have the motivation to continue the medication. This study will offer different methods for treating IDA, including a different method to taking the oral iron therapy. This new method gives oral iron by increasing a family's understanding and motivation. Another research study that interviewed families of young children with IDA found ways that helped the patients to continue their therapy. Using that information, a website called IRONCHILD was created to help motivate parents to get their children to continue the oral iron medicine. Research studies that compare these different IDA treatment methods in young children are needed and could have benefits to short-term clinical and long-term brain development. However, we do not know whether families of young children with IDA will be willing to participate in this type of study that has different treatment methods (oral iron therapy and oral iron therapy with a web-based adherence intervention). The goal of this clinical research study is to learn which of the two methods of care will be the best way for children with iron deficiency anemia to receive therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 3CompletedFinished
202120222023202420252026
First PostedMay 1, 2020
Enrollment StartJul 9, 2021
Primary CompletionFeb 1, 2022
Study CompletionMar 9, 2022
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 6.2 years ago

Interventions

Ferrous Sulfatedrug

Patients receive ferrous sulfate 3 mg/kg elemental iron once daily in liquid formulation.

IRONCHILDbehavioral

Delivery of the intervention at each visit should take 15 minutes or less. * Baseline visit (Session 1) content will be viewed * At 1-month follow-up visit, additional (Session 2) content will be viewed * At 3-month final visit, patients will view final (Session 3) content